Review


DOI :10.26650/IUITFD.2020.0008   IUP :10.26650/IUITFD.2020.0008    Full Text (PDF)

NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES

Ezgi Gizem BerkaySeher Başaran

Recurrent pregnancy losses are seen in approximately 1-3% of the world’s pregnancies and it has been a subject that has been studied for years. Pregnancy includes the production of fertile cells, fertilization, implantation, embryological development processes, the formation of the placenta, the provision of feto-maternal blood circulation and the continuity of pregnancy. Factors affecting an associated pathway in any of these processes may be the underlying cause of pregnancy loss. With the new technologies, it has started to be shown that genetic factors in etiology in pregnancy losses are not only chromosome anomalies, but also single-gene mutations or different genetic factors. The identification of new gene/s and the understanding of the activity of the pathways are compelling enough to change the diagnosis and treatment approaches in the unexplained cases group.  

DOI :10.26650/IUITFD.2020.0008   IUP :10.26650/IUITFD.2020.0008    Full Text (PDF)

TEKRARLAYAN GEBELİK KAYIPLARINDA ETİYOLOJİNİN AÇIKLANMASINA YÖNELİK YENİ YAKLAŞIMLAR

Ezgi Gizem BerkaySeher Başaran

Tekrarlayan gebelik kayıpları tüm dünyada yaklaşık %1-3 oranında görülmekte olup, yıllardır üzerinde çalışılan bir konudur. Gebelik, üreme hücrelerinin üretiminden başlayarak, fertilizasyon, implantasyon, embriyolojik gelişim süreçleri, plasentanın oluşumu, feto-maternal kan dolaşımının sağlanması ve gebeliğin devamını kapsayan oldukça geniş ve farklı süreçleri içermektedir. Bu süreçlerden herhangi birinde, ilişkili bir yolağı etkileyen faktörler gebelik kayıplarında altta yatan sebep olabilir. Yeni teknolojiler ile birlikte gebelik kayıplarında etiyolojide yer alan genetik faktörlerin sadece kromozom anomalileri değil, tek gen mutasyonları ya da farklı genetik faktörlerin de olduğu gösterilmektedir. Yeni gen/lerin tanımlanması ve yolakların aktivitesinin anlaşılması sebebi açıklanamayan olgu grubunda tanı ve tedavi yaklaşımlarını değiştirebilecek güçtedir.


PDF View

References

  • 1. Practice Committee Opinion of the American Society for Reproductive Medicine (ASRM). Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012;98(5):1103-11. [CrossRef] google scholar
  • 2. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü (2014). 2013 Türkiye Nüfus ve Sağlık Araştırması. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü, T.C. Kalkınma Bakanlığı ve TÜBİTAK, Ankara, Türkiye. google scholar
  • 3. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü (2019). 2018 Türkiye Nüfus ve Sağlık Araştırması. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü, T.C. Cumhurbaşkanlığı Strateji ve Bütçe Başkanlığı ve TÜBİTAK, Ankara, Türkiye. google scholar
  • 4. Kolte AM, van Oppenraaji RH, Quenby S, Farquharson RG, Stephenson M, Goddijn M. Eshre, S.I.G.E.P. Nonvisualized pregnancy loses are prognostically important for unexplained recurrent miscarriage. Human Reproduction 2014;29:931-7. [CrossRef] google scholar
  • 5. Kutteh WH. Novel strategies for the management of Recurrent Pregnancy Loss. Semin Reprod Med 2015;33:161-8. [CrossRef] google scholar
  • 6. Yatsenko AN, Turek PJ. Reproductive genetics and the aging male. J Ass Rep Gen 2018;35:933-41. [CrossRef] google scholar
  • 7. Goddijn M, Christiensen OB, Elson J. Recurrent Pregnancy Loss, Guideline of European Society of Human Reproduction and Embriology; 2017 (November). google scholar
  • 8. Royal College Obstetricians and Gynecologists (RCOG). The Investigation and Treatment of Couples with Recurrent first Trimester and Second Trimester Miscarriage. R Coll Obstet Gynaecol 2011;17:1-18. google scholar
  • 9. Lee S-K, Na BJ, Kim JY, Hur SE, Lee M, Gilman-Sachs A, et al. Determination of Clinical Cellular Immune Markers in Women with Recurrent Pregnancy Loss. Am J Reprod Immunol 2013;70(5):398-411. [CrossRef] google scholar
  • 10. Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee S-K, Beaman K. Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 2008;89(1):157-65. [CrossRef] google scholar
  • 11. Ford HB, Schust DJ, Recurrent pregnancy loss: etiology, diagnosis and therapy. Rev Obstet Gyneacol 2009;2(2):76-83. google scholar
  • 12. Rote NS, Lyden TW, Vogt E, Ng AK. Chapter 18: Antiphospolipid antibodies and placental development. In: Hunt JS, editor. Immunobiology of Reproduction. New York: Springer-Verlag; 1994:285-302. [CrossRef] google scholar
  • 13. Katsuragawa H, Kazaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphotidyl serine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997;56:50-8. [CrossRef] google scholar
  • 14. DiSimone N, Costelleie R, Caliandro D, Caruso A, Monoclonal anti-annexin V antibody inhibits trophoblast gonadotrophin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2011;65:1766-70. [CrossRef] google scholar
  • 15. Girardi G, Bulla R, Salmon JE, Tedesco F. The complement system in the pathophysiology of pregnancy. Mole Immunol 2006;43:68-77. [CrossRef] google scholar
  • 16. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N. Engl J Med 1997;337(3):148-53. [CrossRef] google scholar
  • 17. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornay A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18(1):93-101. [CrossRef] google scholar
  • 18. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010;25(9):2203-2209. [CrossRef] google scholar
  • 19. Mehta S, Gupta B editors. Recurrent Pregnancy Loss. Springer Nature Singapore Pte Ltd; 2018. [CrossRef] google scholar
  • 20. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001;7:161-74. [CrossRef] google scholar
  • 21. Jaslow C. Uterin factor. Obstet Gynecol Clin North Am 2014;41(1):57-86. [CrossRef] google scholar
  • 22. Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol 2011;18(5):569-81. [CrossRef] google scholar
  • 23. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007;21:37590. [CrossRef] google scholar
  • 24. Sheekohi S, Mojarrad M, Raoofian R, Ahmadzadeh S, Mirzaie S, Hassanzadeh-Nazarabadi M. Chromosomal study of couples with the history of recurrent spontaneous abortions with diagnosed blighted ovum. Int J Mol Cell Med 2013;2(4):164-8. google scholar
  • 25. Annan JJK, Gudi A, Bhide P, Shah A, Homburg R. Biochemical pregnancy during assisted conception: a little bit pregnant. J Clin Med Res 2013;5(4):269-74. [CrossRef] 26. Wang J, Fan HC, Behr B, Quake SR. Genome-wide single cell analysis of recombination activity and de novo mutation rates in human sperm. Cell 2012;150(2):402-12. [CrossRef] google scholar
  • 27. van den Boogard E, Hermens RPMG, Verhoeve HR, Kremer JAM, van der Veen F, Knegt AC, et al. Selective karyotyping in recurrent miscarriage: are recommended guidelines adopted in daily practice?. Hum Reprod 2011;26:1965-70. google scholar
  • 28. Levy B, Wapner R. Prenatal Diagnosis by Chromosomal Microarray Analysis. Fertil Steril 2018;109(2):201-12. [CrossRef] google scholar
  • 29. Lindqvist PG. Debate: Should thromboprophylaxis be used in hereditary thrombophilias with recurrent pregnancy loss? No. Editör: Carp H.J.A. Recurrent pregnancy loss, causes, controversies, and treatment, second edition. CRC Press. Florida: 2015. google scholar
  • 30. Sullivan AE, Lewis T, Stephenson M, Odem R, Schreiber J, Ober C,et al. Pregnancy outcome in recurrent miscarriage patients with skewed X chromosome inactivation. Obstet Gynecol 2003;101(6):1236-42. [CrossRef] google scholar
  • 31. Moghbeli M. Genetics of recurrent pregnancy loss among Iranian population. Mol Genet Genomic Med. 2019;7:e891. [CrossRef] google scholar
  • 32. Kolte AM, Nielsen HS, Moltke I, Degn B, Pedersen B, Sunde L,et al. A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggest genetic linkage. Mol Hum Reprod 2011;17(6):379-85. [CrossRef] google scholar
  • 33. Su M-T, Lin S-H, Chen Y-C. Genetic association studies of angiogenesis and vasoconstriction related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update 2011;17:803-12. [CrossRef] google scholar
  • 34. Suzuki T, Behnam M, Ronasian F, Salehi M, Shiina M, Koshimizu E,et al. A homozygous NOP14 variant is likely to cause recurrent pregnancy loss. J Hum Genet 2018;63:42530. [CrossRef] google scholar
  • 35. Shehab O, Tester DJ, Ackerman NC, Cowchock FS, Ackerman MJ. Whole genome sequencing identifies etiology of recurrent male intrauterine fetal death. Prenat Diagn 2017;37:1040-5. [CrossRef] google scholar
  • 36. Spellicy CJ, Norris J, Bend R, Bupp C, Mester P, Reynolds T,et al. Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects. Eur J Hum Genet 2018;26(3):420-7. [CrossRef] google scholar
  • 37. Shamseldin HE, Swaid A, Alkuraya FS. Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing. Genet Med 2013;15:307-9. [CrossRef] google scholar
  • 38. Docherty LE, Rezwan FI, Poole RL, Turner CL, Kivuva E, Maher ER, et al. Mutations in NLRP5 are associated with reproductive wastage and multilocus imprinting disorders in humans. Nat Commun 2015;6:8086. [CrossRef] google scholar
  • 39. Quintero-Ronderos P, Mercier E, Fukuda M, Gonzalez R, Suarez CF, Patarroyo MA, et al. Novel genes and mutations in patients affected by recurrent pregnancy loss. PLoS One 2017;12:e0186149. [CrossRef] google scholar
  • 40. Cristofoli F, de Keersmaecker B, de Catte L, Vermeesch JR, Van Esch H. Novel STIL compund heterozygous mutations cause severe fetal microcephaly and centriolar lengthening. Mol Syndromol 2017;8:282-93. [CrossRef] google scholar
  • 41. Qiao Y, Wen J, Tng F, Martell S, Shomer N, Leung PC, et al. Whole exome sequencing in recurrent early pregnancy loss. Mol Hum Reprod 2016;22(5):364-72. [CrossRef] 42. Tsurusaki Y, Yonezawa R, Furuya M, Nishimura G, Pooh RK, Nakashima M, et al. Whole exome sequencing revealed biallelic IFT122 mutations in a family with CED1 and recurrent pregnancy loss. Clin Genet 2014;85:592-4. [CrossRef] google scholar
  • 43. Qian J, Nguyen NMP, Rezaei M, Huang B, Tao Y, Zhang X, et al. Biallelic PADI6 variants linking infertility, miscarriages and hydatidiform moles. Eur J Hum Genet 2018;26:1007-13. [CrossRef] google scholar
  • 44. Pan H, Xiang H, Wang J, Wei Z, Zhou Y, Liu B, et al. CAPS mutations are potentially associated with unexplained recurrent pregnancy loss. Am J Pathol 2019;189(1):124-31. [CrossRef] google scholar
  • 45. Wilbe M, Ekvali S, Eurenius K, Ericson K, Casar-Borota O, Klar J, et al. MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). J Med Genet 2015;52:195202. [CrossRef] google scholar
  • 46. Begemann M, Rezwan FI, Beygo J, Docherty LE, Kolarova J, Schroeder C, et al. Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring. J Med Genet 2018;55:497-504. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Berkay, E.G., & Başaran, S. (2021). NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES. Journal of Istanbul Faculty of Medicine, 84(1), 135-144. https://doi.org/10.26650/IUITFD.2020.0008


AMA

Berkay E G, Başaran S. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES. Journal of Istanbul Faculty of Medicine. 2021;84(1):135-144. https://doi.org/10.26650/IUITFD.2020.0008


ABNT

Berkay, E.G.; Başaran, S. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 1, p. 135-144, 2021.


Chicago: Author-Date Style

Berkay, Ezgi Gizem, and Seher Başaran. 2021. “NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES.” Journal of Istanbul Faculty of Medicine 84, no. 1: 135-144. https://doi.org/10.26650/IUITFD.2020.0008


Chicago: Humanities Style

Berkay, Ezgi Gizem, and Seher Başaran. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES.” Journal of Istanbul Faculty of Medicine 84, no. 1 (May. 2024): 135-144. https://doi.org/10.26650/IUITFD.2020.0008


Harvard: Australian Style

Berkay, EG & Başaran, S 2021, 'NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES', Journal of Istanbul Faculty of Medicine, vol. 84, no. 1, pp. 135-144, viewed 13 May. 2024, https://doi.org/10.26650/IUITFD.2020.0008


Harvard: Author-Date Style

Berkay, E.G. and Başaran, S. (2021) ‘NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES’, Journal of Istanbul Faculty of Medicine, 84(1), pp. 135-144. https://doi.org/10.26650/IUITFD.2020.0008 (13 May. 2024).


MLA

Berkay, Ezgi Gizem, and Seher Başaran. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 1, 2021, pp. 135-144. [Database Container], https://doi.org/10.26650/IUITFD.2020.0008


Vancouver

Berkay EG, Başaran S. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES. Journal of Istanbul Faculty of Medicine [Internet]. 13 May. 2024 [cited 13 May. 2024];84(1):135-144. Available from: https://doi.org/10.26650/IUITFD.2020.0008 doi: 10.26650/IUITFD.2020.0008


ISNAD

Berkay, EzgiGizem - Başaran, Seher. NEW APPROACHES TO EXPLAINING THE ETIOLOGY IN RECURRENT PREGNANCY LOSSES”. Journal of Istanbul Faculty of Medicine 84/1 (May. 2024): 135-144. https://doi.org/10.26650/IUITFD.2020.0008



TIMELINE


Submitted27.01.2020
Accepted03.02.2020
Published Online15.05.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.